FDA Wants to Ban Another Natural Supplement with Success in Treating Symptoms of COVID-19

A few weeks ago, we told you about the FDA’s recent actions threatening NAC supplements—products which the FDA has allowed on the market for decades.

The question is, why now, after all these years, is the FDA doing this?

Digging a bit deeper, it seems obvious that the FDA is clearing the market of affordable NAC supplements in an effort to eliminate competition for NAC drugs that could be coming to market in the next few years.

If our suspicions are correct, this would be another outrageous example of the FDA doing Big Pharma’s dirty work.

To briefly recap how we got here: In a slew of warning letters sent last year, the FDA targeted a number of supplement companies marketing “unapproved” cures for hangovers—which the agency absurdly considers to be a “disease.”

Some of these products contain NAC. In the letters to those companies, the FDA states that NAC does not meet the legal definition of a supplement because it was approved as a drug in 1963; according to federal law, any substance approved as a drug before it was sold as a supplement cannot be sold as a supplement. All of this means that the status of NAC as a supplement is currently in dispute.

So, why is the FDA threatening NAC now, during a pandemic when a new FDA commissioner hasn’t even been appointed? For starters, a drug company is investigating NAC as a treatment for a rare genetic disorderthat damages the myelin sheath, which insulates nerve cells in the brain. The Phase 1 trial was completed in March 2020.

But that’s just the beginning. A search through the government’s clinical trials database shows…